Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Natàlia Vilor‐Tejedor, Alyssa Stevensson et al.|JAMA Neurology|2021Cited by 627
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PETCécile Tissot, Pedro Rosa‐Neto, Joseph Therriault et al.|EBioMedicine|2022Cited by 76
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individualsJoel Simrén, Kaj Blennow, Wagner S. Brum et al.|Alzheimer s Research & Therapy|2022Cited by 33
Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s diseaseJaime Fernández Arias, Pedro Rosa‐Neto, Joseph Therriault et al.|Brain Communications|2023Cited by 16
Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak stagingArthur C. Macedo, Pedro Rosa‐Neto, Joseph Therriault et al.|Brain Communications|2024Cited by 16